Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 4 (1) , 9-15
- https://doi.org/10.1054/drup.2001.0181
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- In vivo veritas: Bcl-2 and Bcl-XLmediate tumor cell resistance to chemotherapyDrug Resistance Updates, 2000
- Dendritic Cells in Cancer ImmunotherapyAnnual Review of Immunology, 2000
- Bid-induced Conformational Change of Bax Is Responsible for Mitochondrial Cytochrome c Release during ApoptosisThe Journal of cell biology, 1999
- A Matter of Life and Cell DeathScience, 1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- Mitochondria and ApoptosisScience, 1998
- Bid, a Bcl2 Interacting Protein, Mediates Cytochrome c Release from Mitochondria in Response to Activation of Cell Surface Death ReceptorsCell, 1998
- Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease CascadePublished by Elsevier ,1997
- Apoptosis in cancer therapy: Crossing the thresholdCell, 1994